Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Moxifloxacin vs IP Ceftazidime for PD Peritonitis
NCT02787057Completed
- Sponsor
- Peking University First Hospital
- Start
- Nov 2012
- Primary completion
- Apr 2016
- Modality
- Orthosteric Ligands
01
Overview
Randomised, open-label trial of moxifloxacin in peritonitis (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Complete Cure Rate. Started Nov 2012; status: completed.
02
Drugs
moxifloxacin
03
Conditions
peritonitis
Beyond the preview
Go deeper on NCT02787057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787057.